Country Profile

Mali

Mali is a growing market for Indian pharmaceuticals — $23.5M in FY 2025–26. Medicines accounts for 76% of shipments, with vaccines contributing $5.21M.

🇲🇱 $23.5M · 1.2× growth since FY2015 · 1.9% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$23.5M
Exports FY2025–26 DGCIS
1.2×
Growth FY2015→2026
1.9%
CAGR FY2015→2026
76%
Medicines Share
5
Product Categories Supplied
Mali is a growing market for Indian pharmaceuticals — $23.5M in FY 2025–26. Medicines accounts for 76% of shipments, with vaccines contributing $5.21M.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $17.8M (75.7%) Vaccines $5.21M (22.1%) Surgical & Hospital Supplies $466K (2.0%) Traditional & Herbal $30K (0.1%) Medicine Ingredients $16K (0.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Mali in the RBI overseas direct investment dataset (2011–2026).